Benzinga’s “Daily Brief On Trending Tickers” features the top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.
The data on the trending tickers is compiled from a list of most-discussed tickers on the popular Reddit forum WallStreetBets.
Netflix Inc (NASDAQ: NASDAQ:NFLX) shares slumped over 27% during Wednesday’s pre-market session after announcing less-than-expected first-quarter revenue and a loss of net paid subscribers.
ASML Holding NV (NASDAQ: AS:ASML) shares are trading 5.97% higher during Wednesday’s pre-market session amid the company's better than expected first-quarter EPS and sales results.
Abbott Laboratories (NYSE: NYSE:ABT) shares are trading 2.68% lower during Wednesday’s pre-market session after reporting better than expected EPS and revenue results.
Procter & Gamble Co (NYSE: PG) shares are trading 1.31% higher during Wednesday’s pre-market session after the company reported better than expected EPS and sales growth.
Sono Group NV (NASDAQ: SEV) shares are trading 5.92% lower during Wednesday’s pre-market session due to profit-taking after the company reported its 2021 financial results on Tuesday. The stock jumped over 65% during Tuesday's trading session.
Also Read: No Parallels Between Netflix And Tesla, Says Ark Analyst
Anthem Inc (NYSE: NYSE:ANTM) beat estimated earnings by 5.63%, reporting an EPS of $8.25. At the same time, revenue grew by $5.79 billion over the same period last year, causing shares to move 2.31% higher during Wednesday’s pre-market session.
Lululemon Athletica Inc (NASDAQ: NASDAQ:LULU) aims to double its revenue to $12.5 billion by 2026 through its Power of Three ×2 growth strategy, which includes a plan to fold men's and digital revenues and quadruple international revenues relative to 2021.
Windtree Therapeutics Inc (NASDAQ: WINT) shares are trading 40% higher during Wednesday’s pre-market session as the company announced topline results from its phase 2 seismic study of istaroxime in early cardiogenic results.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Read at Benzinga